trending Market Intelligence /marketintelligence/en/news-insights/trending/CxTDNe77GAOcCFff0eJLfw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Kitov Pharma prices $6M registered direct offering of American depositary shares

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Kitov Pharma prices $6M registered direct offering of American depositary shares

Kitov Pharma Ltd. priced a registered direct offering of 3,428,572 American depositary shares at $1.75 apiece.

The Israeli drug developer expects to raise $6 million in gross proceeds from the offering.

Kitov Pharma will also issue unregistered warrants to purchase up to 2,571,430 ADSs. Each warrant can be exercised at $2 per ADS for a period of five and a half years.

H.C. Wainwright & Co. is the exclusive placement agent for the offering.

Tel Aviv, Israel-based Kitov Pharma expects to close the offering on or about Jan. 18 subject to closing conditions.